The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Sebastian Ewen

Showing 1-11 of 11 articles
Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial
Scheller B, Ohlow M, Ewen S, Kische S, Rudolph T, Clever Y, Wagner A, Richter S, El-Garhy M, Böhm M, Degenhardt R, Mahfoud F, Lauer B
April 17, 2020 | 10.4244/EIJ-D-19-00723
Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications
Ewen S, Lauder L, Azizi M, Kandzari D, Pathak A, Sharif F, Wijns W, Mahfoud F, Lüscher T
August 3, 2018 | 10.4244/EIJY18M07_1
Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medications
Lauder L, Ewen S, Azizi M, Mauri L, Lurz P, Lobo M, Sharif F, Wijns W, Tsioufis C, Mahfoud F
August 3, 2018 | 10.4244/EIJY18M07_2
Other
Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertension
Lauder L, Ewen S, Tzafriri A, Edelman E, Lüscher T, Blankestijn P, Dörr O, Schlaich M, Sharif F, Voskuil M, Zeller T, Ukena C, Scheller B, Böhm M, Mahfoud F
May 20, 2018 | 10.4244/EIJ-D-18-00112
Interventions for hypertension
Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure control
Ewen S, Lobo M, Pathak A, Schmieder R, Tsioufis C, Wijns W, Mahfoud F
August 20, 2016 | 10.4244/EIJV12I6A132
Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity
Pathak A, Coleman L, Roth A, Stanley J, Bailey L, Markham P, Ewen S, Morel C, Despas F, Honton B, Senard J, Fajadet J, Mahfoud F
August 20, 2015 | 10.4244/EIJV11I4A96
From SYMPLICITY HTN-3 to the Renal Denervation Global Registry: where do we stand and where should we go?
Pathak A, Ewen S, Fajadet J, Honton B, Mahfoud F, Marco J, Schlaich M, Schmieder R, Tsioufis C, Ukena C, Zeller T
May 20, 2014 | 10.4244/EIJV10I1A4
Response and non-response to renal denervation: who is the ideal candidate?
Ukena C, Cremers B, Ewen S, Böhm M, Mahfoud F
May 21, 2013 | 10.4244/EIJV9SRA10
Expanding the indication spectrum: renal denervation in diabetes
Mahfoud F, Ewen S, Ukena C, Linz D, Sobotka P, Cremers B, Böhm M
May 21, 2013 | 10.4244/EIJV9SRA20
Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure
Böhm M, Ewen S, Linz D, Reil J-C, Schirmer S, Ukena C, Mahfoud F
May 21, 2013 | 10.4244/EIJV9SRA21
First-in-human experience: percutaneous renal denervation through a false lumen fenestration in aortic dissection type B
Ewen S, Mahfoud F, Böhm M
January 18, 2013 | 10.4244/EIJV8I9A170

Latest news

NEW ISSUE
A State of the Art on cardiogenic shock; a trial of balloon-based techniques for calcified lesions; a mini focus on spontaneous coronary artery dissection, and more…
August 27, 2021
AHEAD OF PRINT
ViV TAVI vs repeat SAVR
Monil Majmundar et al.
September 15, 2021
EDITORIAL
New European insights on SCAD: are we any closer in our scientific exploration voyage?
Jacqueline Saw et al
August 27, 2021
EDITORIAL
Severely calcified coronary stenoses: a war or a battle?
Emanuele Barbato et al
September 3, 2021
ESC LATEST SCIENCE
TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type
George Dangas et al
August 26, 2021
AHEAD OF PRINT
Thrombectomy for ischaemic stroke
Christopher A. Rajkumar et al.
September 10, 2021
EDITORIAL
Dabigatran-based dual antithrombotic therapy for patients with AF and STEMI undergoing pci
Dominick J. Angiolillo et al
August 27, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke